T-CELL LYMPHOMA

Clinical trials for T-CELL LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new T-CELL LYMPHOMA trials appear

Sign up with your email to follow new studies for T-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 9 Not yet recruiting 1 Not yet finished but already full! 1 Completed 3

New drug aims to stop Lymphoma's return after transplant

Disease control Ongoing

This study is testing if taking a pill called duvelisib after a patient's own stem cell transplant can help keep T-cell lymphoma from coming back. The goal is to see if this approach is safe and if it helps patients live longer without their cancer progressing. The trial is for a…

Matched conditions: T-CELL LYMPHOMA

Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control

Last updated Apr 01, 2026 20:26 UTC

T-CELL LYMPHOMA

Get alerted when new T-CELL LYMPHOMA trials appear

New drug aims to stop Lymphoma's return after transplant